000 03563nam a2200349 a 4500
003 EG-GiCUC
005 20250223031911.0
008 180108s2017 ua do f m 000 0 eng d
040 _aEG-GiCUC
_beng
_cEG-GiCUC
041 0 _aeng
049 _aDeposite
097 _aM.Sc
099 _aCai01.09.08.M.Sc.2017.Ib.A
100 0 _aIbrahim Samy Kalboush
245 1 2 _aA comparative assessment of gcf level of dkk1 after non surgical periodontal therapy with and without topical application of melatonin in chronic periodontitis patients with type {u2161} diabetes mellitus :
_bRandomized clinical trial /
_cIbrahim Samy Kalboush ; Supervised Mona Salah Darhous , Rasha Wageh Mostafa , Olfat Shaker
246 1 5 _aتقييم مقارن لمستوى ال (دى كى كى إى) فى السائل اللثوى حول السنى بعد العلاج اللثوى غير الجراحى مع و بدون الاستخدام الموضعى للميلاتونين فى المرضى المصابين بالتهاب الانسجة الدعامية حول السنية المزمنة مع النوع الثانى من مرض السكر :
_bتجربة سريرية عشوائية
260 _aCairo :
_bIbrahim Samy Kalboush ,
_c2017
300 _a119 P. :
_bcharts , photographs ;
_c25cm
502 _aThesis (M.Sc.) - Cairo University - Faculty of Oral and Dental Medicine - Department of Periodontology
520 _aPeriodontitis is a chronic inflammatory process that occurs in response to a predominantly gram-negative bacterial infection originating in dental plaque. Diabetes and periodontal disease are two chronic diseases that have long been considered to be biologically linked. A large amount of studies and reviews report the adverse effects of diabetes on the onset, progression and severity of periodontal disease. The Wnt (wingless) /Ý-catenin signaling (also termed canonical Wnt pathway), have been implicated in the regulation of bone homeostasis. Inhibition of Wnt antagonists as DKK1 considerably increases bone mass, bone formation, and bone density in humans and animals. Melatonin affect bone metabolism not only by decreasing osteoclast-related bone resorption but also by promoting osteoblast proliferation, differentiation and mineralizing by regulating Wnt signaling pathways. The aim of the present study was to evaluate the effect of locally delivered melatonin as adjunct to non surgical periodontal therapy on the GCF level of DKK1 in chronic periodontitis patients with type II diabetes mellitus. This study was conducted on 44 patients, suffering from chronic peridontitis with type II diabetes mellitus divided into two groups as following: Intervention group (A): consisted of 22 patients (12 females and 10 males) with mean age 50.3±5.8 years and range from 41 to 59 years, were treated by non-surgical periodontal therapy (scaling and root planning) then topical application of melatonin gel inside the pocket. Control group (B): consisted of 22 patients (10 females and 12 males) with mean age 49.8±5.9 years and range from 41 to 59 years, were treated by non surgical periodontal therapy (scaling and root planning) only
530 _aIssued also as CD
653 4 _aChronic periodontitis
653 4 _aDiabetes mellitus
653 4 _aMelatonin
700 0 _aMona Salah Darhous ,
_eSupervisor
700 0 _aOlfat Shaker ,
_eSupervisor
700 0 _aRasha Wageh Mostafa ,
_eSupervisor
856 _uhttp://172.23.153.220/th.pdf
905 _aNazla
_eRevisor
905 _aSamia
_eCataloger
942 _2ddc
_cTH
999 _c64455
_d64455